All Stories

  1. The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers

    Article • Journal of the Renin-Angiotensin-Aldosterone System, January 2019, SAGE Publications

    Michio FUKUDA

  2. Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy

    Article • Physiological Reports, June 2017, Wiley

    Michio FUKUDA

  3. L/T-type calcium channel blocker reduces non-Gaussianity of heart rate variability in chronic kidney disease patients under preceding treatment with ARB

    Article • Journal of the Renin-Angiotensin-Aldosterone System, June 2016, SAGE Publications

    Dr Hidekatsu Fukuta, Michio FUKUDA

  4. Intrarenal RAAS during HCTZ treatment combined with ARB.

    Article • Journal of the Renin-Angiotensin-Aldosterone System, June 2016, SAGE Publications

    Michio FUKUDA